ID   K9TCC-PU-In
AC   CVCL_DN22
SY   K9TCC-In
DR   Wikidata; Q54899442
RX   PubMed=18562222;
RX   PubMed=26401343;
RX   PubMed=29732388;
CC   Doubling time: 41.2 +- 12.2 hours (PubMed=18562222).
CC   Omics: Array-based CGH.
CC   Omics: CNV analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: German Shepherd.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
RX   PubMed=18562222; DOI=10.1016/j.urolonc.2008.02.015;
RA   Dhawan D., Ramos-Vara J.A., Stewart J.C., Zheng R., Knapp D.W.;
RT   "Canine invasive transitional cell carcinoma cell lines: in vitro
RT   tools to complement a relevant animal model of invasive urinary
RT   bladder cancer.";
RL   Urol. Oncol. 27:284-292(2009).
//
RX   PubMed=26401343; DOI=10.1186/s40575-015-0028-3;
RA   Shapiro S.G., Knapp D.W., Breen M.;
RT   "A cultured approach to canine urothelial carcinoma: molecular
RT   characterization of five cell lines.";
RL   Canine Genet. Epidemiol. 2:15.1-15.14(2015).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167;
RA   Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.;
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//